Page last updated: 2024-11-02

phenoxybenzamine and MEA 2a

phenoxybenzamine has been researched along with MEA 2a in 2 studies

Phenoxybenzamine: An alpha-adrenergic antagonist with long duration of action. It has been used to treat hypertension and as a peripheral vasodilator.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Iglesias, P1
Santacruz, E1
García-Sancho, P1
Marengo, AP1
Guerrero-Pérez, F1
Pian, H1
Fajardo, C1
Villabona, C1
Díez, JJ1
Joseph, JV1
Harrison, R1
Davis, RS1

Other Studies

2 other studies available for phenoxybenzamine and MEA 2a

ArticleYear
Pheochromocytoma: A three-decade clinical experience in a multicenter study.
    Revista clinica espanola, 2021, Volume: 221, Issue:1

    Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adrenergic alpha-Antagonists; Adult; Age

2021
Multiple endocrine neoplasia type IIA (Sipple's syndrome) presenting in pregnancy.
    The Australian & New Zealand journal of obstetrics & gynaecology, 2000, Volume: 40, Issue:4

    Topics: Adrenal Gland Neoplasms; Adrenalectomy; Adult; Antihypertensive Agents; Calcitonin; Drug Monitoring;

2000